The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a topical ivermectin solution to treat New World screwworm infestations in horses. This regulatory action follows the detection of the parasite in the United States and provides veterinarians with a critical tool to manage potential outbreaks and prevent the spread of this reportable, foreign animal disease.
Regulatory Action and Emergency Use Authorization
On October 23, 2024, the FDA announced it had issued an EUA for a topical ivermectin solution specifically to address New World screwworm (Cochliomyia hominivorax) in horses. According to the FDA’s official notice, this decision was prompted by the need for effective treatment options should the parasite be identified in equine populations.
The authorization allows for the use of a specific topical formulation of ivermectin, a drug typically used for parasite control in livestock, to kill screwworm larvae in open wounds. The agency clarified that this authorization is limited to the equine species and is intended to supplement existing biosecurity measures.
Understanding the New World Screwworm Threat
The New World screwworm is not a typical fly; it is the larva of a parasitic fly that feeds on the living tissue of warm-blooded animals. Unlike other blowflies that lay eggs in decaying carcasses, the female screwworm fly is attracted to fresh, open wounds.
According to the United States Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS), the larvae burrow into the flesh, creating deep, painful lesions that can be fatal if left untreated. The parasite was officially eradicated from the United States in 1966 through the release of sterile male flies, but it remains a persistent threat in parts of South and Central America. The potential for reintroduction via imported animals or equipment necessitates strict surveillance and emergency preparedness.
Clinical Guidance for Veterinarians
The FDA’s authorization outlines specific protocols for the application of the ivermectin solution. Veterinarians are tasked with diagnosing the infestation, which often presents as a foul-smelling wound with visible larvae.
- Diagnosis: Practitioners should inspect all wounds on horses, particularly those that appear deep or are not healing as expected.
- Treatment: The authorized topical solution is applied directly to the affected area to eliminate the larvae.
- Reporting: Because the New World screwworm is a reportable disease, any suspected or confirmed case must be immediately reported to state or federal animal health authorities.
The FDA emphasizes that this EUA does not replace the need for rigorous wound management and supportive care. Owners should monitor their animals closely, especially in regions where the risk of fly strike is elevated.
Comparison of Control Strategies
Managing screwworm risk involves a multi-layered approach. While topical treatments are vital for individual animal health, they are only one component of a broader eradication strategy.
| Strategy | Primary Objective | Scope |
|---|---|---|
| Topical Ivermectin | Kill larvae in current wounds | Individual Animal |
| Sterile Insect Technique | Prevent reproduction of wild flies | Population/Regional |
| Biosecurity/Quarantine | Prevent entry of infested animals | National/Border |
The shift toward utilizing topical ivermectin under emergency protocols underscores the importance of having rapid-response tools ready for immediate deployment. By providing a clear regulatory pathway for this treatment, the FDA aims to mitigate the morbidity and mortality associated with potential screwworm incursions while protecting the broader livestock industry from the economic impact of an outbreak.
Related reading